How ARKG’s Genomics Will Personalize Cancer Treatment

by | Mar 31, 2021 | BioTech Stocks, Outside Takes, Tech Stocks

This is originally from post published on on ETFTrends.com.

Patients may suffer from the same ailments, but no two medical problems are exactly alike. That much is confirmed by genetic code, indicating the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is an avenue for investors looking to tap into increasing levels of personalized care in cancer treatment. ARKG includes companies that merge healthcare with […]

The post How ARKG’s Genomics Will Personalize Cancer Treatment appeared first on ETF Trends.


This is originally from post published on on ETFTrends.com.

>

Pin It on Pinterest

Share This